Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12. (Q39807698)

14 September 2017

Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12. (English)

1 reference

14 September 2017

0 references

12

Igor Nenadic

1 reference

14 September 2017

15

Heinrich Sauer

1 reference

14 September 2017

6

Rachel A Yotter

1 reference

14 September 2017

1

Stefan Smesny

1 reference

14 September 2017

Christina Kunstmann

2

1 reference

14 September 2017

Sebastian Kunstmann

3

1 reference

14 September 2017

Ingo Willhardt

4

1 reference

14 September 2017

Juergen Lasch

5

1 reference

14 September 2017

Tina-Marie Proffitt

7

1 reference

14 September 2017

Melissa Kerr

8

1 reference

14 September 2017

Conny Marculev

9

1 reference

14 September 2017

Berko Milleit

10

1 reference

14 September 2017

Christine Milleit

11

1 reference

14 September 2017

Paul Amminger

13

1 reference

14 September 2017

Patrick D McGorry

14

1 reference

14 September 2017

Gregor E Berger

16

1 reference

14 September 2017

14 December 2010

1 reference

World Journal of Biological Psychiatry

14 September 2017

1 reference

14 September 2017

12

1 reference

14 September 2017

598-607

1 reference

14 September 2017

8

1 reference

Regulation and inhibition of phospholipase A2.

14 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Increased platelet phospholipase A2 activity in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Causes and consequences of the gender difference in age at onset of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Fatty acid levels in the brains of schizophrenics and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Identification of the calmodulin-binding domain of recombinant calcium-independent phospholipase A2beta. implications for structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Fluorometric assays of phospholipase A2 activity with three different substrates in biological samples of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

The role of phospholipases A2 in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

The investigation of cytosolic phospholipase A2 using ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Elevated PLA2 activity in schizophrenics and other psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Increased platelet membrane lysophosphatidylcholine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

A bromoenol lactone suicide substrate inactivates group VIA phospholipase A2 by generating a diffusible bromomethyl keto acid that alkylates cysteine thiols

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Increased phospholipase A2 activity in schizophrenia with absent response to niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique--preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics--a study including 50 patients and 36 controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

Protease activation of calcium-independent phospholipase A2 leads to neutrophil recruitment to coronary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.541283

10.3109/15622975.2010.541283

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference